UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.27-37

2019

Volltextzugriff (PDF)

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.2917-2929

2018

Volltextzugriff (PDF)

Clinical Trial Design for Mild-to-Moderate Community-Acquired Pneumonia—An Industry Perspective

Clinical infectious diseases, 2008-12, Vol.47 (Supplement-3), p.S166-S175

2008

Volltextzugriff (PDF)

Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis

Clinical infectious diseases, 1999-07, Vol.29 (1), p.113-119

1999

Volltextzugriff (PDF)

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women

The American journal of medicine, 1999-03, Vol.106 (3), p.292-299

1999

Volltextzugriff (PDF)

Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults

Epilepsy research, 2021-01, Vol.169, p.106478-106478, Article 106478

2021

Volltextzugriff (PDF)

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Efficacy And Safety Of Sun-101/eflow® (nebulized Glycopyrrolate) In Moderate-To-Very-Severe COPD: Results From The Glycopyrrolate For Obstructive Lung Disease Via Electronic Nebulizer (golden) 3 And 4 Studies

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: A Long-Term Safety Study Of Arformoterol Tartrate In The Maintenance Therapy Of Patients With Moderate To Severe COPD: Sensitivity Analyses For Potential Impact Of Missing Data

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Randomized, Double-Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

Clinical infectious diseases, 1998-10, Vol.27 (4), p.722-729

1998

Volltextzugriff (PDF)

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

Journal of cardiovascular pharmacology and therapeutics, 1997, Vol.2 (1), p.7-16

1997

Volltextzugriff (PDF)

Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

Clinical infectious diseases, 1998-10, Vol.27 (4), p.722

1998

Volltextzugriff (PDF)

Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group

Annals of otology, rhinology & laryngology, 1999-04, Vol.108 (4), p.360-367

1999

Volltextzugriff (PDF)

Controlled trial of acifran in type II hyperlipoproteinemia

Clinical pharmacology and therapeutics, 1985-09, Vol.38 (3), p.313-317

1985

Volltextzugriff (PDF)

Double-Blind Comparative Trial of Ciprofloxacin versus Clarithromycin in the Treatment of Acute Bacterial Sinusitis

Annals of otology, rhinology & laryngology, 1999-04, Vol.108 (4), p.360-367

1999

Volltextzugriff (PDF)

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

The American journal of medicine, 1999-03, Vol.106 (3), p.292

1999

Volltextzugriff (PDF)

Short-Course Ciproflox Treatment of Acute Uncomplicated Urinary Tract Infection in Women: The Minimum Effective Dose

Archives of internal medicine (1960), 1995-03, Vol.155 (5), p.485

Iravani, Abdollah

1995

Volltextzugriff (PDF)

Prevention of Travelers' Diarrhea: Ciprofloxacin versus Trimethoprim/Sulfamethoxazole in Adult Volunteers Working in Latin America and the Caribbean

Journal of travel medicine, 1994-09, Vol.1 (3), p.136-142

1994

Volltextzugriff (PDF)

Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group

Journal of otolaryngology, 1999-02, Vol.28 (1), p.3

1999

Volltextzugriff (PDF)

Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]

Archives of internal medicine (1960), 1995-03, Vol.155 (5), p.485-494

1995

Volltextzugriff (PDF)

Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control

American journal of human genetics, 2010, Vol.86 (1), p.88-92

2010

Volltextzugriff (PDF)

Confounding Issues in COPD Risk Study?

Chest, 2003-01, Vol.123 (1), p.307-307

2003

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Adult
(8)
Biological And Medical Sciences
(8)
Female
(8)
Medical Sciences
(8)
Middle Aged
(8)
Aged
(7)
Acute Disease
(6)
Adolescent
(6)
Double-Blind Method
(6)
Treatment Outcome
(6)
Male
(5)
Pharmacology. Drug Treatments
(5)
Aged, 80 And Over
(4)
Chronic Obstructive Pulmonary Disease
(4)
Ciprofloxacin - Therapeutic Use
(4)
Prospective Studies
(4)
Anti-Bacterial Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

Clinical Trial Design for Mild-to-Moderate Community-Acquired Pneumonia—An Industry Perspective

Demographic, Clinical, and Treatment Parameters Influencing the Outcome of Acute Cystitis

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women

Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18–59 years) adults

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Efficacy And Safety Of Sun-101/eflow® (nebulized Glycopyrrolate) In Moderate-To-Very-Severe COPD: Results From The Glycopyrrolate For Obstructive Lung Disease Via Electronic Nebulizer (golden) 3 And 4 Studies

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: A Long-Term Safety Study Of Arformoterol Tartrate In The Maintenance Therapy Of Patients With Moderate To Severe COPD: Sensitivity Analyses For Potential Impact Of Missing Data

Randomized, Double-Blind Study of Ciprofloxacin and Cefuroxime Axetil for Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis

Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia

Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group

Controlled trial of acifran in type II hyperlipoproteinemia

Double-Blind Comparative Trial of Ciprofloxacin versus Clarithromycin in the Treatment of Acute Bacterial Sinusitis

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

Short-Course Ciproflox Treatment of Acute Uncomplicated Urinary Tract Infection in Women: The Minimum Effective Dose

Prevention of Travelers' Diarrhea: Ciprofloxacin versus Trimethoprim/Sulfamethoxazole in Adult Volunteers Working in Latin America and the Caribbean

Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group

Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]

Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control

Confounding Issues in COPD Risk Study?

Suchergebnisse filtern